Search Results

Gefitinib 250 mg  | ≥98%

LKT Laboratories, Inc.

EGFR inhibitor.

More Information Supplier Page

×

Gefitinib

Gefitinib 100 mg  | ≥98%

LKT Laboratories, Inc.

EGFR inhibitor.

More Information Supplier Page

×

Gefitinib

Gentamycin Sulfate 10 g  | ≥98%

LKT Laboratories, Inc.

Aminoglycoside; protein translation inhibitor.

More Information Supplier Page

×

Gentamycin Sulfate

Gentamycin Sulfate 5 g  | ≥98%

LKT Laboratories, Inc.

Aminoglycoside; protein translation inhibitor.

More Information Supplier Page

×

Gentamycin Sulfate

Gentamycin Sulfate 1 g  | ≥98%

LKT Laboratories, Inc.

Aminoglycoside; protein translation inhibitor.

More Information Supplier Page

×

Gentamycin Sulfate

Gabapentin 50 mg  | ≥98%

LKT Laboratories, Inc.

GABA analog; GABA potentiator, adenosine A1 agonist, voltage-gated α2δ Ca2+ channel blocker, NMDA modulator.

More Information Supplier Page

×

Gabapentin

Gabapentin 10 mg  | ≥98%

LKT Laboratories, Inc.

GABA analog; GABA potentiator, adenosine A1 agonist, voltage-gated α2δ Ca2+ channel blocker, NMDA modulator.

More Information Supplier Page

×

Gabapentin

γ-Amino Butyric Acid 100 g  | ≥98%

LKT Laboratories, Inc.

Endogenous neurotransmitter; GABA agonist.

More Information Supplier Page

×

γ-Amino Butyric Acid

γ-Amino Butyric Acid 25 g  | ≥98%

LKT Laboratories, Inc.

Endogenous neurotransmitter; GABA agonist.

More Information Supplier Page

×

γ-Amino Butyric Acid

γ-Amino Butyric Acid 10 g  | ≥98%

LKT Laboratories, Inc.

Endogenous neurotransmitter; GABA agonist.

More Information Supplier Page

×

γ-Amino Butyric Acid